These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 27429017)

  • 1. Survival After Neoadjuvant and Adjuvant Treatments Compared to Surgery Alone for Resectable Esophageal Carcinoma: A Network Meta-analysis.
    Pasquali S; Yim G; Vohra RS; Mocellin S; Nyanhongo D; Marriott P; Geh JI; Griffiths EA
    Ann Surg; 2017 Mar; 265(3):481-491. PubMed ID: 27429017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer.
    Kranzfelder M; Schuster T; Geinitz H; Friess H; Büchler P
    Br J Surg; 2011 Jun; 98(6):768-83. PubMed ID: 21462364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A network meta-analysis for neoadjuvant and adjuvant treatments for resectable squamous cell carcinoma of esophagus.
    Zhao Y; Wang Y; Shan L; Peng C; Zhang W; Zhao X
    Sci Rep; 2021 Mar; 11(1):6800. PubMed ID: 33762694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review and network meta-analysis of neoadjuvant therapy combined with surgery for patients with resectable esophageal squamous cell carcinoma.
    Huang Y; Wang H; Luo G; Zhang Y; Wang L; Li K
    Int J Surg; 2017 Feb; 38():41-47. PubMed ID: 28027995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant treatments for locally advanced, resectable esophageal cancer: A network meta-analysis.
    Chan KKW; Saluja R; Delos Santos K; Lien K; Shah K; Cramarossa G; Zhu X; Wong RKS
    Int J Cancer; 2018 Jul; 143(2):430-437. PubMed ID: 29441562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemotherapy for resectable esophageal carcinoma: a meta-analysis of randomized clinical trials.
    Xu XH; Peng XH; Yu P; Xu XY; Cai EH; Guo P; Li K
    Asian Pac J Cancer Prev; 2012; 13(1):103-10. PubMed ID: 22502650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Skeletal Muscle Mass During Neoadjuvant Chemoradiotherapy Predicts Postoperative Mortality in Esophageal Cancer Surgery.
    Reisinger KW; Bosmans JW; Uittenbogaart M; Alsoumali A; Poeze M; Sosef MN; Derikx JP
    Ann Surg Oncol; 2015 Dec; 22(13):4445-52. PubMed ID: 25893413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy versus surgery alone for esophageal squamous cell carcinoma: a meta-analysis of randomized controlled trials and nonrandomized studies.
    Zhang SS; Yang H; Xie X; Luo KJ; Wen J; Bella AE; Hu Y; Yang F; Fu JH
    Dis Esophagus; 2014 Aug; 27(6):574-84. PubMed ID: 23621119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Negative Survival Impact of Infectious Complications After Surgery is Canceled Out by the Response of Neoadjuvant Chemotherapy in Patients with Esophageal Cancer.
    Kano K; Aoyama T; Yoshikawa T; Maezawa Y; Nakajima T; Hayashi T; Yamada T; Sato T; Oshima T; Rino Y; Masuda M; Cho H; Ogata T
    Ann Surg Oncol; 2018 Jul; 25(7):2034-2043. PubMed ID: 29748890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do We Need to Add Postoperative Radiotherapy in Patients Undergoing Trimodality Therapy for Esophageal Squamous Cell Carcinoma with Positive Lymph Nodes Disease?
    Huang PM; Hsu FM; Lin CC; Hsu CH; Cheng JC; Lee JM
    Dig Surg; 2018; 35(2):104-110. PubMed ID: 28675905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different recurrence pattern after neoadjuvant chemoradiotherapy compared to surgery alone in esophageal cancer patients.
    Smit JK; Güler S; Beukema JC; Mul VE; Burgerhof JG; Hospers GA; Plukker JT
    Ann Surg Oncol; 2013 Nov; 20(12):4008-15. PubMed ID: 23838922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The optimal strategy of multimodality therapies for resectable gastric cancer: evidence from a network meta-analysis.
    Yin S; Wang P; Xu X; Tan Y; Huang J; Xu H
    J Cancer; 2019; 10(14):3094-3101. PubMed ID: 31289579
    [No Abstract]   [Full Text] [Related]  

  • 13. Outcome of neoadjuvant therapies for cancer of the oesophagus or gastro-oesophageal junction based on a national data registry.
    Klevebro F; Lindblad M; Johansson J; Lundell L; Nilsson M
    Br J Surg; 2016 Dec; 103(13):1864-1873. PubMed ID: 27689845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08).
    Ruhstaller T; Thuss-Patience P; Hayoz S; Schacher S; Knorrenschild JR; Schnider A; Plasswilm L; Budach W; Eisterer W; Hawle H; Mariette C; Hess V; Mingrone W; Montemurro M; Girschikofsky M; Schmidt SC; Bitzer M; Bedenne L; Brauchli P; Stahl M; ; ; ;
    Ann Oncol; 2018 Jun; 29(6):1386-1393. PubMed ID: 29635438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis.
    Malthaner RA; Wong RK; Rumble RB; Zuraw L;
    BMC Med; 2004 Sep; 2():35. PubMed ID: 15447788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncologic Outcomes According to Remnant Lymph Node Metastases in Pathologic T0 (ypT0) Esophageal Squamous Cell Carcinoma Following Prospective Neoadjuvant Therapy and Surgery.
    Cho HJ; Kim YH; Kim HR; Kim DK; Park SI; Kim JH; Kim SB
    Ann Surg Oncol; 2015; 22(6):1851-7. PubMed ID: 25344308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodality treatment of locally advanced squamous cell carcinoma of the oesophagus: A comprehensive review and network meta-analysis.
    Montagnani F; Fornaro L; Frumento P; Vivaldi C; Falcone A; Fioretto L
    Crit Rev Oncol Hematol; 2017 Jun; 114():24-32. PubMed ID: 28477744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elective nodal irradiation versus involved-field irradiation in patients with esophageal cancer receiving neoadjuvant chemoradiotherapy: a network meta-analysis.
    Liu T; Ding S; Dang J; Wang H; Chen J; Li G
    Radiat Oncol; 2019 Oct; 14(1):176. PubMed ID: 31619265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Optimal Treatment for Resectable Esophageal Cancer: A Network Meta-Analysis of 6168 Patients.
    Yuan M; Bao Y; Ma Z; Men Y; Wang Y; Hui Z
    Front Oncol; 2021; 11():628706. PubMed ID: 33777777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.
    Gebski V; Burmeister B; Smithers BM; Foo K; Zalcberg J; Simes J;
    Lancet Oncol; 2007 Mar; 8(3):226-34. PubMed ID: 17329193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.